Congratulations to our portfolio company Carthera on another milestone in its work treating patients with recurrent glioblastoma.
🔈We are pleased to announce that Carthera has received a positive opinion from French High Authority for Health on Innovation Funding scheme to treat patients with recurrent #glioblastoma “The positive opinion from the French High Authority for Health on Forfait Innovation is a recognition of the significant innovation likely to be delivered to glioblastoma patients by the SonoCloud device,” said Professor Alexandre Carpentier, head of the neurosurgery department at AP-HP Sorbonne University, inventor of SonoCloud and founder of Carthera. “It also acknowledges that the proposed SONOBIRD study should be able to answer the primary endpoint question about the overall survival associated with administration of carboplatin chemotherapy after BBB opening using SonoCloud.” Read the full press release👇 https://lnkd.in/ebGNAgmi Frédéric Sottilini Carole Desseaux Michael Canney, Ph.D. Haute Autorité de Santé #medtech #HAS #forfaitinnovation #oncology #neurology #clinicaltrials #chemotherapy #therapeuticultrasound